You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 463 Metastatic gastric cancer patient benefiting from combined radio-immunotherapy treatment displayed sustained anti-NY-ESO-1 specific T cells and expressed important immuno-modulatory markers

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Combination immunotherapies
463 Metastatic gastric cancer patient benefiting from combined radio-immunotherapy treatment displayed sustained anti-NY-ESO-1 specific T cells and expressed important immuno-modulatory markers

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 20209508
Dec 20206009
Jan 20213204
Feb 20211804
Mar 20215008
Apr 20213203
May 2021704
Jun 2021004
Jul 2021002
Aug 2021008
Sep 2021005
Oct 202118016
Nov 202145021
Dec 20213602
Jan 20223005
Feb 20223403
Mar 20224401
Apr 20224805
May 20224202
Jun 20224202
Jul 20223007
Aug 20225604
Sep 20222601
Oct 20222201
Nov 20226201
Dec 20224603
Jan 20238202
Feb 20232401
Mar 20233605
Apr 20231406
May 2023601
Jun 2023401
Jul 20231004
Aug 20231201
Sep 2023400
Oct 20231802
Nov 20231802
Dec 20232602
Jan 20243202
Feb 20242400
Mar 20241601
Apr 20241603
May 20242201
Jun 20243603
Jul 20242508
Aug 20241602
Sep 20241603
Oct 20241206
Nov 20241402
Dec 20246805
Jan 20251808
Feb 20252404
Mar 2025002
Apr 2025004
May 2025002
Jun 2025003
Total14680219